PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 146 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $871,000 | -20.4% | 172,337 | -2.8% | 0.01% | -12.5% |
| Q2 2019 | $1,094,000 | +15.4% | 177,379 | -13.1% | 0.01% | +14.3% |
| Q1 2019 | $948,000 | +15.5% | 204,203 | +4.5% | 0.01% | +16.7% |
| Q4 2018 | $821,000 | -11.7% | 195,378 | +31.7% | 0.01% | 0.0% |
| Q3 2018 | $930,000 | +8.1% | 148,382 | +38.7% | 0.01% | 0.0% |
| Q2 2018 | $860,000 | +22.3% | 106,983 | +13.5% | 0.01% | 0.0% |
| Q1 2018 | $703,000 | +51.8% | 94,248 | +21.0% | 0.01% | +100.0% |
| Q4 2017 | $463,000 | -9.0% | 77,867 | +12.5% | 0.00% | -25.0% |
| Q3 2017 | $509,000 | +18.4% | 69,204 | +9.2% | 0.00% | +33.3% |
| Q2 2017 | $430,000 | -24.4% | 63,387 | +5.2% | 0.00% | -25.0% |
| Q1 2017 | $569,000 | -2.2% | 60,265 | -10.5% | 0.00% | 0.0% |
| Q4 2016 | $582,000 | +70.2% | 67,319 | -14.2% | 0.00% | 0.0% |
| Q1 2016 | $342,000 | -39.4% | 78,505 | -14.6% | 0.00% | -33.3% |
| Q4 2015 | $564,000 | -91.0% | 91,959 | -15.7% | 0.01% | -14.3% |
| Q3 2015 | $6,239,000 | +1109.1% | 109,075 | +57.8% | 0.01% | +75.0% |
| Q2 2015 | $516,000 | +150.5% | 69,122 | +100.2% | 0.00% | +100.0% |
| Q1 2015 | $206,000 | – | 34,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|